{
  "id": 7981391,
  "title": "Bayer: FDA Approves Kerendia To Treat Chronic Kidney Disease Associated With Type 1 Diabetes",
  "url": "https://urgent.news/2026/09/17/bayer-fda-approves-kerendia-to-treat-chronic-kidney-disease",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-17T07:06:11.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/bayer-fda-approves-kerendia-treat-chronic-kidney-disease-associated-type-1-diabetes"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Bayer (BYR.L, BAY.MI, BAYN.DE) announced the FDA has approved Kerendia or finerenone for the treatment of adult patients with chronic kidney disease associated with type 1 diabetes. The approval represents the third approved indication for Kerendia in the U.S. Fineren",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}